Colecchia, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.826
EU - Europa 1.877
AS - Asia 1.735
SA - Sud America 54
AF - Africa 15
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 6
Totale 7.526
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.818
HK - Hong Kong 690
CN - Cina 584
SE - Svezia 500
IT - Italia 499
SG - Singapore 316
GB - Regno Unito 269
BG - Bulgaria 202
DE - Germania 111
FI - Finlandia 98
BR - Brasile 48
ID - Indonesia 48
IE - Irlanda 45
LT - Lituania 29
IR - Iran 24
UA - Ucraina 21
RO - Romania 20
TR - Turchia 19
FR - Francia 16
IN - India 14
AU - Australia 12
BE - Belgio 10
VN - Vietnam 10
CZ - Repubblica Ceca 9
JP - Giappone 8
MK - Macedonia 7
NL - Olanda 7
PK - Pakistan 7
EG - Egitto 6
ES - Italia 6
EU - Europa 6
KR - Corea 6
PL - Polonia 6
RU - Federazione Russa 6
TN - Tunisia 6
AT - Austria 5
CA - Canada 5
CL - Cile 5
MY - Malesia 4
MX - Messico 3
PH - Filippine 3
GR - Grecia 2
HR - Croazia 2
NG - Nigeria 2
SM - San Marino 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BY - Bielorussia 1
CH - Svizzera 1
DK - Danimarca 1
GE - Georgia 1
HU - Ungheria 1
LU - Lussemburgo 1
MA - Marocco 1
NZ - Nuova Zelanda 1
Totale 7.526
Salva come PNG Salva come JPEG
Città #
Hong Kong 685
Fairfield 645
Nyköping 472
Chandler 331
Ashburn 264
Wilmington 248
Princeton 238
Woodbridge 231
San Diego 225
Singapore 216
Cambridge 203
Sofia 202
Houston 199
Beijing 187
Seattle 143
New York 111
Helsinki 82
London 75
Buffalo 61
Southend 57
Ann Arbor 55
Modena 55
Jakarta 46
Dublin 42
Milan 42
Bologna 41
São Paulo 40
Rome 38
Bremen 37
Jacksonville 33
Shanghai 33
Kilburn 29
Norwalk 27
Dearborn 21
Guangzhou 20
Mashhad 18
Prescot 14
Hounslow 13
Chiswick 11
Florence 11
Timisoara 11
Izmir 10
Lappeenranta 10
Palermo 10
Brno 9
Brussels 9
Council Bluffs 9
Parma 9
Reggio Emilia 9
Chicago 8
Rimini 8
Eugene 7
Southwark 7
Turin 7
Wuhan 7
Acton 6
Bari 6
Carpi 6
Des Moines 6
Tanta 6
Hangzhou 5
Hanover 5
Padova 5
Redwood City 5
San Mateo 5
Vienna 5
Vitória 5
Wandsworth 5
Augusta 4
Catania 4
Cesena 4
Cluj-Napoca 4
Dallas 4
Hanoi 4
Iasi 4
Istanbul 4
Jinhua 4
Leeds 4
Manchester 4
Munich 4
North Kansas City 4
Paris 4
Sydney 4
Washington 4
Adelaide 3
Amsterdam 3
Assago 3
Brescia 3
Casteldaccia 3
Chengdu 3
Frankfurt am Main 3
Ho Chi Minh City 3
Legnaro 3
Los Angeles 3
Megrine 3
Melbourne 3
Pavia 3
Perugia 3
Phoenix 3
Piacenza 3
Totale 5.813
Salva come PNG Salva come JPEG
Nome #
Gut Microbiota and Celiac Disease. 203
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice 163
Incidence of gallstone disease in Italy: Results from a multicenter, population-based Italian study (the MICOL project) 160
Non-invasive methods can predict oesophageal varices in patients with biliary atresia after a Kasai procedure. 155
Natural history of gallstone disease: Expectant management or active treatment? Results from a population-based cohort study. 151
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study 117
Growth and nutritional evaluation in children with chronic liver disease (CLD) before and after liver transplantation 80
Differences in liver stiffness values obtained with new ultrasound elastography machines and Fibroscan: A comparative study 78
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation 75
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 73
Adverse Food Reaction and Functional Gastrointestinal Disorders: Role of the Dietetic Approach 73
A novel spleen-dedicated stiffness measurement by FibroScan® improves the screening of high-risk oesophageal varices 72
Clinical manifestations of gallstone disease: evidence from the multicenter Italian study on cholelithiasis (MICOL) 69
C-11 Acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma 66
DAAs treatment in HCV recurrence after liver transplantation: Clinical usefulness of non-invasive methods 63
DAAs treatment in hepatitis C virus recurrence after Liver Transplantation: clinical usefulness of non-invasive methods 59
A new point-of-care portable immunosensor for non-invasive assessment of oro-ileal transit time by oral fluid tauroursodeoxycholate measurement after its oral load 58
A RETROSPECTIVE STUDY ON INTRAHEPATIC CHOLESTASIS OF PREGNANCY: MARKERS OF PREMATURE DELIVERY 57
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 57
Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis 54
Gut microbiota signatures and clinical manifestations in celiac disease children at onset: a pilot study 54
An explorative data-analysis to support the choice between hepatic resection and radiofrequency ablation in the treatment of hepatocellular carcinoma 54
Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: Predictive role in HCC development in cirrhotic patients 52
"Are the Expanded Baveno VI Criteria really safe to screen compensated cirrhotic patients for high-risk varices?" 51
Liver and spleen stiffness and other noninvasive methods to assess portal hypertension in cirrhotic patients: a review of the literature 51
Relationship between hepatic hemodynamics assessed by Doppler ultrasound and liver stiffness 50
Spleen Stiffness Measurements Predict the Risk of Hepatic Decompensation after Direct-Acting Antivirals in HCV Cirrhotic Patients 50
Association between PNPLA3rs738409 polymorphism decreased kidney function in postmenopausal type 2 diabetic women with or without non-alcoholic fatty liver disease 50
Pre-transplant psoas muscle density as a ready-to-use and low-cost predictor of patient survival after liver transplant 50
Feasibility, safety, and outcome of second-line nivolumab/bevacizumab in liver transplant patients with recurrent hepatocellular carcinoma 48
Role of Vitamin D in Liver Disease and Complications of Advanced Chronic Liver Disease 48
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals 48
THU-492 - Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patients 48
Adding Liver Stiffness Measurement to the Routine Evaluation of Hepatocellular Carcinoma Resectability Can Optimize Clinical Outcome 47
Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis 47
Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia 47
Predictive factors for hepatocellular carcinoma recurrence after curative treatments 46
Probiotics, Prebiotics and Other Dietary Supplements for Gut Microbiota Modulation in Celiac Disease Patients 46
A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis 46
Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma 45
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 45
Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation 44
A spleen stiffness measurement-based model for recognition of high risk varices: Baveno VI criteria and beyond 43
A SPLEEN STIFFNESS MEASUREMENT-BASED MODEL FOR THE RECOGNITION OF HIGH RISK VARICES: BAVENO VI CRITERIA AND BEYOND 43
Clinical presentation of celiac disease and diagnosis accuracy in a single-center european pediatric cohort over 10 years 43
Antibiotic prophylaxis in patients with cirrhosis: Current evidence for clinical practice 43
Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma 42
Gut microbiota and metabolic syndrome 40
Review article:the diagnosis of non-alcoholic fatty liver disease-availability and accuracy of non-invasive methods 40
Restaging Patients With Hepatocellular Carcinoma Before Additional Treatment Decisions: A Multicenter Cohort Study 39
A spleen stiffness measurement-based model for the recognition of high risk varices: Baveno VI criteria and beyond 39
Diverticular disease of the colon: new perspectives in symptom development and treatment 39
Hepatic steatosis in obese patients: clinical aspects and prognostic significance 39
Regolazione dei trasportatori placentari degli acidi biliari MRP2, MRP3, MRP4 da parte dell’acido ursodesossicolico in corso di colestasi gravidica 39
The evolutionary scenario of hepatocellular carcinoma in Italy: an update 39
HEPATIC DECOMPENSATION RISK IS REDUCED, BUT NOT ELIMINATED AFTER DIRECT-ACTING ANTIVIRALS: THE ROLE OF SPLEEN STIFFNESS MEASUREMENT 38
Bacteria flora,gas and antibiotics 38
IMPULSIONAL, POINT AND BIDIMENSIONAL SHEAR WAVE ELASTOMETRY FOR PORTAL HYPERTENSION: SAME STIFFNESS THRESHOLDS? 37
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 37
Are noninvasive methods clinically useful in advanced, decompensated liver cirrhosis when "les Jeux Sont Faits"? 37
Ten year incidence of HCV infection in northern Italy and frequency of spontaneous viral clearance 37
Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension 37
Autoimmune liver diseases in a paediatric population with coeliac disease. A 10-year single-centre experience 36
Clinical impact of sarcopenia assessment in patients with liver cirrhosis 36
Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model 35
Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments 35
Prognostic Value of the Albumin-Bilirubin Grade for the Prediction of Post-Hepatectomy Liver Failure: A Systematic Review and Meta-Analysis. 34
Dysbiosis in Celiac disease patients with persistent symptoms on gluten-free diet: a condition similar to that present in irritable bowel syndrome patients? 34
Long-term alpha interferon and lamivudine combination therapy in non-responder patients with anti-HBe-positive chronic hepatitis B: results of an open, controlled trial 34
Primary biliary cholangitis-primary sclerosing cholangitis in an evolving overlap syndrome: A case report 33
A Nomogram-Based Prognostic Model for Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib: A Multicenter Study 33
Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes 33
The role of liver and spleen elastography in advanced chronic liver disease 33
Gallbladder motility and gallstone formation in obese patients following very low calorie diets. Use it (fat) to lose it (well) 32
Risk of hepatocellular carcinoma after HCV eradication: Determining the role of portal hypertension by measuring spleen stiffness. 32
Benign hepatic nodular lesions after treatment for childhood cancer 32
Italian consensus conference for colonic diverticulosis and diverticular disease 32
Post COVID-19 irritable bowel syndrome 31
A Combined Baveno VII and Spleen Stiffness Algorithm to Improve the Noninvasive Diagnosis of Clinically Significant Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease 31
Non-invasive diagnostic approach to non-alcoholic fatty liver disease: current evidence and future perspectives 31
Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations 31
Measurement of hepatic functional mass by means of 13C-methacetin and 13C-phenylalanine breath tests in chronic liver disease: comparison with Child-Pugh score and serum bile acid levels 31
Size and location of spontaneous portosystemic shunts predict the risk of decompensation in cirrhotic patients 31
Pneumocystis jirovecii pneumonia in patients with decompensated cirrhosis: a case series 30
Association between lower plasma adiponectin levels and higher liver stiffness in type 2 diabetic individuals with nonalcoholic fatty liver disease: an observational cross-sectional study 30
Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers 30
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 30
Body weight,lifestyle,dietary habits and gastroesophageal reflux disease 30
Transient Elastography (FibroScan) Is Not Correlated With Liver Fibrosis but With Cholestasis in Patients With Long-Term Home Parenteral Nutrition 30
Non-invasive tests for the prediction of primary hepatocellular carcinoma 29
Fish oil based emulsion for the treatment of parenteral nutrition associated liver disease in adult patient 29
Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease 29
Spleen stiffness decrease as mirror of portal hypertension changes after successful interferon-free therapy in chronic-HCV patients 29
Imaging Software-Based Sarcopenia Assessment in Gastroenterology: Evolution and Clinical Meaning 29
Gut microbiota and its pathophysiology in disease paradigms 29
The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: A multicenter cohort study 29
The role of Spleen Stiffness measurement as predictor of HCC recurrence after curative resection in cirrhotic patients 29
Long-term leukocyte natural α-interferon and ribavirin treatment in hepatitis C virus recurrence after liver transplantation 29
Gastric autoimmune disorders in patients with chronic hepatitis C before, during and after interferon-alpha therapy 29
Liver and Spleen Stiffness Measurements for Assessment of Portal Hypertension Severity in Patients with Budd Chiari Syndrome 28
Totale 4.927
Salva come PNG Salva come JPEG
Categoria #
all - tutte 100.810
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.810
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020207 0 0 0 24 25 42 36 29 21 7 16 7
2020/2021306 14 6 15 17 14 21 16 28 76 27 60 12
2021/20222.566 35 27 12 8 34 29 743 185 338 48 754 353
2022/20231.813 307 184 151 85 162 208 46 249 211 30 87 93
2023/20242.351 30 91 133 139 469 157 129 220 364 140 130 349
2024/2025295 141 33 55 66 0 0 0 0 0 0 0 0
Totale 7.799